HYPR Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Disclosed Revenue Gap Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones PTEN Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Discipline BKV Q1 2026 Earnings EPS Miss Marks Volatile Start IMNN Q1 2026 Earnings Narrowerthanexpected loss drives small share gain IPHA Q1 2026 Earnings WiderThanExpected Losses on Zero Revenue